98044695 - TESCENDO

Information

• Trademark
• 98044695

• Source

• Serial Number

  98044695

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  June 15, 2023
  a year ago

• Transaction Date

  December 17, 2024
  2 months ago

• Status Date

  December 17, 2024
  2 months ago

• Published for Opposition Date

  November 05, 2024
  4 months ago

• Location Date

  December 17, 2024
  2 months ago

• Status Code

  688

• Current Location

  INTENT TO USE SECTION

  Employee Name

  GILLES, DEBORAH

• Attorney Name

  A. Reagan Fibbe

  Law Office Assigned Location Code

  M10

• Owners

  • THE UNIVERSITY OF TEXAS SYSTEM

Case File Statements

• GS0401: Custom manufacturing of pharmaceuticals; providing technical information in the field of pharmaceutical manufacturing; manufacturing of cell therapy platforms for others
• GS0051: Cells for medical or clinical use; pharmaceutical preparations and therapeutic agents for the treatment of cancer, infectious diseases, autoimmune and inflammatory conditions, and genetic diseases and non-genetic endocrine diseases, degenerative diseases, and aging disorders; therapeutic kits comprised of biological and pharmaceutical preparations for use in treatment and therapy for cancer, infectious diseases, autoimmune and inflammatory conditions, and genetic diseases and non-genetic endocrine diseases, degenerative diseases, and aging disorders; test kits for diagnostic preparations for medical purposes comprised of medical diagnostic reagents and assays for testing of body fluids and also containing a sample preparation device for medical diagnostic uses; T-cell receptors expressed on the cell for use in connection with diagnosing and treating cancer, infectious diseases, autoimmune and inflammatory conditions, and genetic diseases and non-genetic endocrine diseases, degenerative diseases, and aging disorders; diagnostic reagents for medical clinical use for treatment of cancer; cell culture kits for medical use primarily comprised of imaging and detection agents for diagnosing and monitoring cancer, and also containing a diagnostic apparatus for medical purposes used in medical laboratories for testing cancer cells; medical testing and treatment product kits primarily comprised of cells for diagnosing and treating cancer, infectious diseases, autoimmune and inflammatory conditions, and genetic diseases and non-genetic endocrine diseases, degenerative diseases, and aging disorders
• GS0011: Reagents for scientific and research purposes, drug discovery research and scientific development, and biological and pharmaceutical reagents, for scientific and research purposes, for use in the manufacturing process of cell therapy platforms; diagnostic reagents for scientific clinical use for treatment of cancer
• GS0441: Medical services; medical services, namely, cellular immunotherapy treatments; medical services, namely, human cancer treatment; providing medical information relating to immunotherapy; providing cancer therapy advice and consultancy
• GS0421: Medical and scientific research services; medical laboratory services; providing information on medical and scientific research in the field of oncology; compiling and analyzing data for research purposes in the field of oncology; consulting in the field of medical and scientific research

Case File Event Statements

• 1/31/2024 - a year ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 6/19/2023 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 7/19/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 5/3/2024 - 10 months ago

  7 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR

• 2/7/2024 - a year ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/7/2024 - a year ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 2/7/2024 - a year ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 5/3/2024 - 10 months ago

  8 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG

• 8/7/2024 - 7 months ago

  11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/7/2024 - 7 months ago

  10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 9/15/2024 - 5 months ago

  14 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 8/7/2024 - 7 months ago

  9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 9/15/2024 - 5 months ago

  15 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 9/24/2024 - 5 months ago

  16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 10/16/2024 - 4 months ago

  17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 11/5/2024 - 4 months ago

  18 - PUBLISHED FOR OPPOSITION Type: PUBO

• 11/5/2024 - 4 months ago

  19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 12/17/2024 - 2 months ago

  20 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 9/15/2024 - 5 months ago

  13 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 9/15/2024 - 5 months ago

  12 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA